All the news Showing 10 of 189 articles from: Disease course and symptomsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Tenofovir may lower the risk of liver cancer more than entecavir Liz Highleyman / 18 April 2019 People with hepatitis B who were treated with tenofovir disoproxil fumarate (TDF; Viread) were less likely to develop hepatocellular carcinoma (HCC) than those treated with entecavir (Baraclude) in a large observational study, according ... Epigenetic changes persist after hepatitis C cure in liver cells, may predict liver cancer Keith Alcorn / 26 March 2019 Hepatitis C infection leaves permanent changes in the activity of genes in the liver even after the infection is cured and these changes are associated with an increased risk of liver cancer, ... Diabetes Development Linked to Hepatocellular Carcinoma, Mortality in Hepatitis B Infectious Disease Adviser / 20 March 2019 Hepatitis C treatment reduces risk of diabetes Liz Highleyman / 18 March 2019 Treatment of hepatitis C virus (HCV) infection is associated with better glucose control and a lower likelihood of developing diabetes, according to a report at the Conference on Retroviruses and Opportunistic Infections (CROI ... Low testosterone persists after HCV clearance Healio / 12 February 2019 Hepatitis C cure does not improve glucose control in type 2 diabetes Michael Carter / 07 February 2019 A successful response to hepatitis C virus (HCV) therapy does not result in long-term improvements in glucose metabolism for people with type 2 diabetes, according to US research published in Liver International. A sustained ... Immunotherapy combinations show promise for liver cancer Liz Highleyman / 04 February 2019 Checkpoint inhibitor immunotherapy combinations may slow disease progression in people with hepatocellular carcinoma (HCC), according to two small studies presented at the 2019 Gastrointestinal Cancers Symposium last month in San Francisco. However, response ... Hepatitis: Liver failure attributable to compromised blood supply Eurekalert / 16 January 2019 Curing Hepatitis C Is Tied to Improved Diabetes Markers Hep / 20 December 2018 Aspirin use associated with lower risk of liver cancer Liz Highleyman / 13 November 2018 Taking aspirin about twice a week for five years or more may reduce the risk of developing hepatocellular carcinoma (HCC) by about half, according to research presented this week at the AASLD Liver ... ← Prev12345...19Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive